For the second consecutive year, the Russian retail market for medical enteral nutrition has shown double-digit growth in both value and volume. According to the RNC Pharma® database “Audit of Retail Sales of Specialized Nutrition in Russia (total sell-out)”, in January–September 2025 the value of sales increased by 19.6%, while volume sales grew by 13.9% compared with the same period in 2024.

Over the first nine months of 2025, Russian consumers purchased 12.3 million packages (equivalent to over 3,000 tons) of medical enteral nutrition, totaling RUB 5.2 billion (in retail prices, including VAT). In 2024, volume sales rose by 19.1% versus 2023, and consumer spending grew by 24.7% over the same period.

The online channel continues to outpace traditional retail, with consumer spending on e-commerce purchases up 37.5% year-on-year, compared to +11.4% growth in offline sales. A similar trend is observed in volume: +29.3% growth in e-commerce versus +8.7% in offline retail. As a result, the share of e-commerce (mainly marketplaces) reached 36.2% in value and 28.5% in volume.

In Q1–Q3 2025, the retail market featured 49 brands of medical nutrition from 18 companies. Over the past three years, 10 new products have entered the market, most of them domestically produced. However, two leading brands continue to dominate: together they account for over 76% of total volume and around 61% of total value.

The category leader remains PediaSure (Abbott, USA) with a 32.1% market share in value terms. Its sales increased by 18% in value and 12% in volume compared with Q1–Q3 2024. In second place is Nutridrink (Nutricia, Danone, Netherlands) with a 29.2% share, showing +21% growth in value and +12% in volume. Alfare (Nestlé) ranked third with 7.1% share; demand declined by 2% in volume, but consumer spending increased by 8%.

All top-10 brands posted positive value dynamics except Peptamen (Nestlé), a specialized product for patients with gastrointestinal disorders and impaired nutrient absorption. Its sales declined mainly in larger pack sizes (400 g and 500 ml), resulting in an overall drop of –7% in value and –10% in volume.

The fastest growth within the top 10 was recorded for the Russian brand Leovit (Leovit Nutrio), whose sales surged by 96% in value and 65% in volume, ranking seventh. Another domestic brand, Nutrien (Infaprim), climbed to fourth place with +39% value and +31% volume growth year-on-year. The product line includes over 30 SKUs and accounted for 5.9% of total market value.

Outside the top 10, the Russian brand Bioshake (Farmalakt), introduced in 2024, showed the most rapid growth — its sales increased fivefold in value and sixfold in volume, though its market share remains modest (around 0.1%).

Top 10 Medical Enteral Nutrition Brands in the Russian Retail Market (including online and FMCG channels), by Value Sales, Q1–Q3 2025